List of works - Pablo Bellot

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

scientific article published on 27 August 2014

Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial

scientific article published on 08 October 2014

Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.

scientific article

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis.

scientific article published on 31 August 2015

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

scientific article

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis

scientific article published on 01 April 2015

Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

scientific article published on 15 December 2010

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.

scientific article published on 14 March 2016

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

scientific article published on 20 December 2006

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

scientific article published on 01 March 2011

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

scientific article published on 29 July 2016

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

scientific article published on 01 May 2004

NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.

scientific article published on 17 November 2009

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

scientific article published on 18 August 2017

Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study

scientific article published in August 2007

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

scientific article

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin

scientific article published on 22 October 2007

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

scientific article published on 05 May 2008

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis

scientific article published on 01 December 2008

The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

scientific article published on 13 March 2010

The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.

scientific article published on 10 June 2016

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

scientific article published on 21 April 2016

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

scientific article published in January 2015

[Bacterial translocation in cirrhosis]

scientific article published on 01 October 2008

[Current problems in the prevention and treatment of infections in patients with cirrhosis]

scientific article published on 04 May 2010

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report]

scientific article published on 08 June 2011

[Usefulness of tomographic computer colonography for colorectal polyp detection].

scientific article

List of works by Pablo Bellot

Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis

Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial

Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.

Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis.

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis

Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis

The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis

[Bacterial translocation in cirrhosis]

[Current problems in the prevention and treatment of infections in patients with cirrhosis]

[Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report]

[Usefulness of tomographic computer colonography for colorectal polyp detection].